A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD ) - Trial NCT05965882
Access comprehensive clinical trial information for NCT05965882 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Institute of Heart, Lung and Blood Vessel Diseases and is currently Recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Timeline & Enrollment
N/A
Jun 01, 2016
Jun 01, 2024
Primary Outcome
Number of hospitalizations for acute heart failure (HF)
Summary
The registry study aims to discover biomarkers for accurate classification and risk
 assessment of ischemic heart disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05965882
Non-Device Trial